Common variants at traf3ip2 are associated with susceptibility to psoriatic arthritis and psoriasis

Common variants at traf3ip2 are associated with susceptibility to psoriatic arthritis and psoriasis

Play all audios:

Loading...

ABSTRACT Psoriatic arthritis (PsA) is an inflammatory joint disease that is distinct from other chronic arthritides and which is frequently accompanied by psoriasis vulgaris (PsV) and


seronegativity for rheumatoid factor. We conducted a genome-wide association study in 609 German individuals with PsA (cases) and 990 controls with replication in 6 European cohorts


including a total of 5,488 individuals. We replicated PsA associations at _HLA-C_ and _IL12B_ and identified a new association at _TRAF3IP2_ (rs13190932, _P_ = 8.56 × 10−17). _TRAF3IP2_ was


also associated with PsV in a German cohort including 2,040 individuals (rs13190932, _P_ = 1.95 × 10−3). Sequencing of the exons of _TRAF3IP2_ identified a coding variant (p.Asp10Asn,


rs33980500) as the most significantly associated SNP (_P_ = 1.13 × 10−20, odds ratio = 1.95). Functional assays showed reduced binding of this TRAF3IP2 variant to TRAF6, suggesting altered


modulation of immunoregulatory signals through altered TRAF interactions as a new and shared pathway for PsA and PsV. Access through your institution Buy or subscribe This is a preview of


subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only


$17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout


ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS DISENTANGLING THE COMPLEXITY


OF PSORIASIS IN THE POST-GENOME-WIDE ASSOCIATION ERA Article 16 September 2023 GWAS META-ANALYSIS OF PSORIASIS IDENTIFIES NEW SUSCEPTIBILITY ALLELES IMPACTING DISEASE MECHANISMS AND


THERAPEUTIC TARGETS Article Open access 28 February 2025 LOW-FREQUENCY AND RARE GENETIC VARIANTS ASSOCIATED WITH RHEUMATOID ARTHRITIS RISK Article 27 March 2024 ACCESSION CODES ACCESSIONS


GENBANK/EMBL/DDBJ * NM_147686 REFERENCES * Ibrahim, G., Waxman, R. & Helliwell, P.S. The prevalence of psoriatic arthritis in people with psoriasis. _Arthritis Rheum._ 61, 1373–1378


(2009). Google Scholar  * Taylor, W. et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. _Arthritis Rheum._ 54, 2665–2673


(2006). Google Scholar  * Karason, A., Love, T.J. & Gudbjornsson, B. A strong heritability of psoriatic arthritis over four generations–the Reykjavik Psoriatic Arthritis Study.


_Rheumatology (Oxford)_ 48, 1424–1428 (2009). Google Scholar  * Elder, J.T. et al. The genetics of psoriasis. _Arch. Dermatol._ 130, 216–224 (1994). Google Scholar  * Feng, B.J. et al.


Multiple loci within the major histocompatibility complex confer risk of psoriasis. _PLoS Genet._ 5, e1000606 10.1371/journal.pgen.1000606 (2009). Google Scholar  * Ho, P.Y. et al.


Investigating the role of the _HLA-Cw*06_ and _HLA-DRB1_ genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. _Ann. Rheum.


Dis._ 67, 677–682 (2008). Google Scholar  * Cargill, M. et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. _Am.


J. Hum. Genet._ 80, 273–290 (2007). Google Scholar  * Filer, C. et al. Investigation of association of the _IL12B_ and _IL23R_ genes with psoriatic arthritis. _Arthritis Rheum._ 58,


3705–3709 (2008). Google Scholar  * de Cid, R. et al. Deletion of the late cornified envelope _LCE3B_ and _LCE3C_ genes as a susceptibility factor for psoriasis. _Nat. Genet._ 41, 211–215


(2009). Google Scholar  * Huffmeier, U. et al. Deletion of _LCE3C_ and _LCE3B_ genes at PSORS4 does not contribute to susceptibility to psoriatic arthritis in German patients. _Ann. Rheum.


Dis._ 69, 876–878 (2009). Google Scholar  * Nair, R.P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. _Nat. Genet._ 41, 199–204 (2009). Google


Scholar  * Liu, Y. et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. _PLoS Genet._ 4, e1000041 (2008). Google Scholar  * Hüffmeier, U.


et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. _J. Invest. Dermatol._ 129, 355–358


(2009). Google Scholar  * Genetic Analysis of Psoriasis Consortium and the Wellcome Trust Case Control Consortium 2. A genome-wide association study identifies new psoriasis susceptibility


loci and an interaction between _HLA-C_ and _ERAP1_. _Nat. Genet._ advance online publication, doi:10.1038/ng.694 (17 October 2010). * Hunter, C.A. Act1-ivating IL-17 inflammation. _Nat.


Immunol._ 8, 232–234 (2007). Google Scholar  * Qian, Y. et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. _Nat.


Immunol._ 8, 247–256 (2007). Google Scholar  * Tesmer, L.A., Lundy, S.K., Sarkar, S. & Fox, D.A. Th17 cells in human disease. _Immunol. Rev._ 223, 87–113 (2008). Google Scholar  *


Schwandner, R., Yamaguchi, K. & Cao, Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. _J. Exp. Med._ 191, 1233–1240


(2000). Google Scholar  * Hoffmann, A. & Baltimore, D. Circuitry of nuclear factor kappaB signaling. _Immunol. Rev._ 210, 171–186 (2006). Google Scholar  * Thomson, W. et al. Rheumatoid


arthritis association at 6q23. _Nat. Genet._ 39, 1431–1433 (2007). Google Scholar  * Barton, A. et al. Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. _Nat.


Genet._ 40, 1156–1159 (2008). Google Scholar  * Raychaudhuri, S. et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. _Nat. Genet._ 40, 1216–1223 (2008). Google


Scholar  * Kanamori, M., Kai, C., Hayashizaki, Y. & Suzuki, H. NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6. _FEBS. Lett._ 532, 241–246 (2002).


Google Scholar  * Li, Y. & Mach Abecasis, G. 1.0: rapid haplotype reconstruction and missing genotype inference. _Am. J. Hum. Genet._ S79, 2290 (2006). Google Scholar  * Purcell, S. et


al. PLINK: a tool set for whole-genome association and population-based linkage analyses. _Am. J. Hum. Genet._ 81, 559–575 (2007). Google Scholar  * Devlin, B. & Roeder, K. Genomic


control for association studies. _Biometrics_ 55, 997–1004 (1999). Google Scholar  * Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association


studies. _Nat. Genet._ 38, 904–909 (2006). Google Scholar  * Uebe, S. et al. GPFrontend and GPGraphics: Graphical analysis tools for genetic association studies. _BMC Bioinformatics_ 11, 472


(2010). Google Scholar  * Huffmeier, U. et al. Characterization of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1.


_J. Med. Genet._ 46, 736–744 (2009). Google Scholar  Download references ACKNOWLEDGEMENTS We are grateful to all subjects and control probands for participation in this study. We thank P.


Rothe, M. Kirsch, P. Badorf, P. Gilbert and K. Krause for excellent technical assistance. We thank D. Fried for helping with the cloning of constructs. The work was supported in part by a


grant from the Interdisciplinary Centre for Clinical Research (IZKF B32/A8) of the University of Erlangen-Nuremberg and a grant from the ELAN fund (Erlanger Leistungsbezogene


Anschubfinanzierung und Nachwuchsförderung) of the University of Erlangen-Nuremberg. The KORA (Cooperative Health Research in the Region of Augsburg) research platform was initiated and


financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of


Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823). Our research was supported within the Munich Center of Health Sciences


(MC Health) as part of LMUinnovativ. We acknowledge the National Institute for Health Research, Manchester Biomedical Research Centre and Science Foundation Ireland for support. A.B.,


I.N.B. and J.B. are funded by Arthritis Research. H.B. and F.B. were supported by a research grant of Wyeth Pharma GmbH, Germany (Forschungsförderungspreis Rheumatologie 2008). E.G. and G.N.


are funded by the ADIPSO (Association for the Defense of Psoriasis Patients). The Irish control DNA was provided by the Irish Blood Transfusion Service and Trinity College Dublin population


DNA Biobank. This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is


available from http://www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. U.H., E.G., E.K., M.A., P.H., I.N.B., F.B., O.F., G.-M.A., N.J.M.,


G.N., H.B., A.B. and A.R. are members of the Psoriatic Arthritis Genetics in Europe (PAGE) Consortium. AUTHOR INFORMATION Author notes * Jesús Lascorz Present address: Present address:


Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., * Ulrike Hüffmeier and Steffen Uebe: These authors contributed equally to this work. *


Harald Burkhardt, Anne Barton and André Reis: These authors jointly supervised this work. AUTHORS AND AFFILIATIONS * Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen,


Germany Ulrike Hüffmeier, Steffen Uebe, Arif B Ekici, Maria Apel, Jesús Lascorz & André Reis * Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre, The


University of Manchester, Manchester, UK John Bowes, Pauline Ho, Ian N Bruce & Anne Barton * Department of Biopathology, Centre of Excellence for Genomic Risk Assessment in


Multifactorial and Complex Diseases, School of Medicine, University of Rome 'Tor Vergata' and Fondazione PTV 'Policlinico Tor Vergata', Rome, Italy Emiliano Giardina 


& Giuseppe Novelli * Royal National Hospital for Rheumatic Diseases, Bath, UK Eleanor Korendowych & Neil J McHugh * Department of Public Health and Clinical Medicine, Rheumatology,


University Hospital, Umeå, Sweden Kristina Juneblad & Gerd-Marie Alenius * Department of Clinical Medicine, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland Ross


McManus & Anthony W Ryan * Division of Rheumatology, Department of Internal Medicine II, Johann Wolfgang Goethe University, Frankfurt am Main, Germany Frank Behrens, Beate Böhm & 


Harald Burkhardt * Department of Dermatology, University of Münster, Münster, Germany Heiko Traupe * Psoriasis Rehabilitation Hospital, Bad Bentheim, Germany Jörg Lohmann * Institute of


Epidemiology, Helmholtz Center Munich, Munich, Germany Christian Gieger & Heinz-Erich Wichmann * Institute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology,


Ludwig-Maximilians-Universität, Munich, Germany Heinz-Erich Wichmann * Klinikum Grosshadern, Munich, Germany Heinz-Erich Wichmann * Institute of Medical Biometry, Informatics and


Epidemiology, University of Bonn, Bonn, Germany Christine Herold, Michael Steffens & Thomas F Wienker * Karolinska Institute, Stockholm, Sweden Lars Klareskog * Department of


Rheumatology, St. Vincent's University Hospital, University College Dublin (UCD) School of Medicine and Medical Science and Conway Institute of Biomolecular and Biomedical Research,


University College Dublin, Dublin, Ireland Oliver FitzGerald * Department of Pharmacy and Pharmacology, University of Bath, Bath, UK Neil J McHugh Authors * Ulrike Hüffmeier View author


publications You can also search for this author inPubMed Google Scholar * Steffen Uebe View author publications You can also search for this author inPubMed Google Scholar * Arif B Ekici


View author publications You can also search for this author inPubMed Google Scholar * John Bowes View author publications You can also search for this author inPubMed Google Scholar *


Emiliano Giardina View author publications You can also search for this author inPubMed Google Scholar * Eleanor Korendowych View author publications You can also search for this author


inPubMed Google Scholar * Kristina Juneblad View author publications You can also search for this author inPubMed Google Scholar * Maria Apel View author publications You can also search for


this author inPubMed Google Scholar * Ross McManus View author publications You can also search for this author inPubMed Google Scholar * Pauline Ho View author publications You can also


search for this author inPubMed Google Scholar * Ian N Bruce View author publications You can also search for this author inPubMed Google Scholar * Anthony W Ryan View author publications


You can also search for this author inPubMed Google Scholar * Frank Behrens View author publications You can also search for this author inPubMed Google Scholar * Jesús Lascorz View author


publications You can also search for this author inPubMed Google Scholar * Beate Böhm View author publications You can also search for this author inPubMed Google Scholar * Heiko Traupe View


author publications You can also search for this author inPubMed Google Scholar * Jörg Lohmann View author publications You can also search for this author inPubMed Google Scholar *


Christian Gieger View author publications You can also search for this author inPubMed Google Scholar * Heinz-Erich Wichmann View author publications You can also search for this author


inPubMed Google Scholar * Christine Herold View author publications You can also search for this author inPubMed Google Scholar * Michael Steffens View author publications You can also


search for this author inPubMed Google Scholar * Lars Klareskog View author publications You can also search for this author inPubMed Google Scholar * Thomas F Wienker View author


publications You can also search for this author inPubMed Google Scholar * Oliver FitzGerald View author publications You can also search for this author inPubMed Google Scholar * Gerd-Marie


Alenius View author publications You can also search for this author inPubMed Google Scholar * Neil J McHugh View author publications You can also search for this author inPubMed Google


Scholar * Giuseppe Novelli View author publications You can also search for this author inPubMed Google Scholar * Harald Burkhardt View author publications You can also search for this


author inPubMed Google Scholar * Anne Barton View author publications You can also search for this author inPubMed Google Scholar * André Reis View author publications You can also search


for this author inPubMed Google Scholar CONTRIBUTIONS H.B., A.B. and A.R. designed the study and worked out its concept. U.H., A.B.E., M.A. and J.B. planned and performed genotyping with


genome-wide arrays and/or assays for single SNPs, and U.H., S.U., A.B.E., J.B., M.A., C.H., M.S., T.F.W. and A.R. analyzed genetic data. B.B. and H.B. performed functional studies. U.H.,


J.B., E.G., E.K., K.J., R.M., P.H., I.N.B., A.W.R., F.B., J. Lascorz, H.T., J. Lohmann, C.G., H.-E.W., O.F., G.-M.A., N.J.M., G.N., H.B. and A.B. recruited subjects and control individuals


and collected the phenotypic data. U.H., S.U., H.B. and A.R. wrote a first draft of the manuscript. A.B. edited the manuscript in a major way. All authors reviewed and approved the


manuscript. CORRESPONDING AUTHOR Correspondence to André Reis. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing financial interests. SUPPLEMENTARY INFORMATION


SUPPLEMENTARY TEXT AND FIGURES Supplementary Figures 1–3, Supplementary Tables 1–4 and Supplementary Note. (PDF 819 kb) RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE


CITE THIS ARTICLE Hüffmeier, U., Uebe, S., Ekici, A. _et al._ Common variants at _TRAF3IP2_ are associated with susceptibility to psoriatic arthritis and psoriasis. _Nat Genet_ 42, 996–999


(2010). https://doi.org/10.1038/ng.688 Download citation * Received: 25 January 2010 * Accepted: 13 September 2010 * Published: 17 October 2010 * Issue Date: November 2010 * DOI:


https://doi.org/10.1038/ng.688 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently


available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative